Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against Trypanosoma cruzi: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease
作者:Leonardo da Silva Lara、Guilherme Curty Lechuga、Lorraine Martins Rocha Orlando、Byanca Silva Ferreira、Bernardo Araújo Souto、Maurício Silva dos Santos、Mirian Claudia de Souza Pereira
DOI:10.3390/pharmaceutics14050995
日期:——
Chagas disease, a century-old disease that mainly affects the impoverished population in Latin America, causes high morbidity and mortality in endemic countries. The available drugs, benznidazole (Bz) and nifurtimox, have limited effectiveness and intense side effects. Drug repurposing, and the development of new chemical entities with potent activity against Trypanosoma cruzi, are a potential source
恰加斯病是一种有百年历史的疾病,主要影响拉丁美洲的贫困人口,在流行国家造成高发病率和死亡率。现有药物苯并硝唑 (Bz) 和硝呋莫司的疗效有限且副作用严重。药物的重新利用以及开发具有有效对抗克氏锥虫活性的新化学实体是治疗选择的潜在来源。本研究基于先前确定的命中系统 5-氨基吡唑-咪唑啉的优化,使用结构-活性关系探索以及基于计算和表型的策略,描述了两个新系列的吡唑-噻唑啉衍生物的生物活性。有前景的候选物2c 、 2e和2i衍生物表现出良好的口服生物利用度和 ADMET 特性,以及低细胞毒性 (CC 50 > 100 µM),此外与 Bz (19.6 ± 2.3 µM) 相比,对锥鞭毛体具有有效的活性 (0.4–2.1 µM) 。其中, 2c也很突出,对细胞内无鞭毛体具有更强的效力 (pIC 50 = 5.85)。所选的吡唑-噻唑啉衍生物在 3D 球体系统中表现出良好的渗透性和有效性,但在冲洗试